Pfanstiehl Overview

  • Founded
  • 1919

Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 99

Employees

  • Latest Deal Type
  • Debt

  • Financing Rounds
  • 5

Pfanstiehl General Information

Description

Manufacturer of low-endotoxin sugars intended for niche pharmaceutical and biotechnological industries. The company offers active pharmaceutical ingredients (APIs), including cytotoxic actives and sugars utilized as injectable excipients for cell culture media, protein stabilization and carbohydrates, enabling clients to get materials for large volume parenteral applications.

Contact Information

Website
www.pfanstiehl.com
Formerly Known As
Ferro Pfanstiehl Laboratories
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 1219 Glen Rock Avenue
  • Waukegan, IL 60085-6230
  • United States
+1 (847) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pfanstiehl Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pfanstiehl‘s full profile, request access.

Request a free trial

Pfanstiehl Patents

  • 6

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Pfanstiehl Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-6211407-B1 Dicreatine citrate comprising two creatine cations per citrate dianion Inactive 03-May-2000 0000000000
US-4474769-A Chitosan as a contraceptive Inactive 13-May-1983 0000000000
US-3985870-A D-glucoheptono-1,4-lactone and calcium compound abrasive Inactive 24-Mar-1971 000000000
US-3022343-A Sequestrant derived from corn syrup and process for making the same Inactive 17-Nov-1959 0000000000
US-3033900-A Method of preparing calcium glucoheptonate Inactive 25-Mar-1958 C07C51/412
To view Pfanstiehl’s complete patent history, request access »

Pfanstiehl Executive Team (6)

Name Title Board Seat Contact Info
James Breckenridge Chairman, Chief Executive Officer & President
Trevor Calkins Chief Technical Officer
Wayne Brownell Vice President, Finance
David Marshall Vice President of Finance and Optimization
You’re viewing 4 of 6 executive team members. Get the full list »

Pfanstiehl Board Members (1)

Name Representing Role Since
00000 000000000000 Pfanstiehl Chairman, Chief Executive Officer & President 000 0000
To view Pfanstiehl’s complete board members history, request access »

Pfanstiehl Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pfanstiehl Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pfanstiehl‘s full profile, request access.

Request a free trial